Second Line Capital, LLC Merck & Co., Inc. Transaction History
Second Line Capital, LLC
- $413 Million
- Q3 2025
A detailed history of Second Line Capital, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Second Line Capital, LLC holds 5,749 shares of MRK stock, worth $533,852. This represents 0.12% of its overall portfolio holdings.
Number of Shares
5,749
Previous 6,078
5.41%
Holding current value
$533,852
Previous $486 Million
99.9%
% of portfolio
0.12%
Previous 0.11%
Shares
8 transactions
Others Institutions Holding MRK
# of Institutions
3,875Shares Held
1.9BCall Options Held
30.1MPut Options Held
27.7M-
Vanguard Group Inc Valley Forge, PA252MShares$23.4 Billion0.33% of portfolio
-
Black Rock Inc. New York, NY207MShares$19.2 Billion0.59% of portfolio
-
State Street Corp Boston, MA118MShares$11 Billion0.35% of portfolio
-
Wellington Management Group LLP Boston, MA75.3MShares$6.99 Billion1.16% of portfolio
-
Geode Capital Management, LLC Boston, MA59.8MShares$5.55 Billion0.33% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $235B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...